Skip to content
TheChatArchiveThe Chat Archive
gpt-3.5-turbo-0301· OpenAIAi2 WildChat-4.8M (AI2)

please revise the sentence for me. Cell that expressed L7Ae-His6 were lysed in buffer C…

  1. User

    please revise the sentence for me. Cell that expressed L7Ae-His6 were lysed in buffer C (1M NaCl, 25 mM phosphate (pH 7.0) and 5% glycerol), then underwent heat treatment and clarification. L7Ae underwent purification using a HisTrap column which was first washed with buffer C that contained 20 mM imidazole. L7Ae was then eluted with buffer M, which contained 500 mM imidazole and 20 mM MES (pH 6.0). L7Ae was subsequently loaded onto two serial HiTrap Blue HP columns in 20 mM MES (pH 6.0) and ultimately eluted in a salt gradient at around 0.5 M Na

  2. Assistant

    The cells expressing L7Ae-His6 were lysed using buffer C (1M NaCl, 25 mM phosphate with pH 7.0, and 5% glycerol), followed by heat treatment and clarification. L7Ae was isolated using a HisTrap column, which was initially washed with buffer C containing 20 mM imidazole. The elution of L7Ae was carried out using buffer M, which consisted of 500 mM imidazole and 20 mM MES (with pH 6.0). Subsequently, L7Ae was applied to two sequential HiTrap Blue HP columns in 20 mM MES (with pH 6.0) and finally eluted through a salt gradient at approximately 0.5 M Na.

  3. User

    The H/ACA RNA genes were amplified from the S. islandicus genomic DNA, and were inserted downstream of a T7 promoter into the pBCSK(+) vector. In vitro transcription reactions were performed at 37°C for 4 hours using T7 RNA polymerase and PCR products as templates. RNAs were then resolved in an 8% polyacrylamide urea gel and subsequently purified. H/ACA RNPs were assembled by combining Cbf5-Nop10, L7Ae, Gar1 and H/ACA RNA in a molar ratio of 1:1:1:1:1.05 in buffer containing 20 mM HEPES (pH 8.2), 150 mM NaCl, 10 mM MgCl2, 1 mM DTT, 0.2 mM EDTA and 10% glycerol. The mixture was then incubated at 65°C for 3 minutes followed by a cooling step at 4°C.

  4. Assistant

    To obtain the H/ACA RNA genes, genomic DNA of S. islandicus was used to amplify the genes and then inserted downstream of a T7 promoter into the pBCSK(+) vector. In vitro transcription reactions were carried out using T7 RNA polymerase and PCR products as templates at 37°C for 4 hours. The resulting RNAs were then separated using an 8% polyacrylamide urea gel and subsequently purified. The H/ACA RNPs were assembled by combining Cbf5-Nop10, L7Ae, Gar1, and H/ACA RNA in a buffer containing 20 mM HEPES (pH 8.2), 150 mM NaCl, 10 mM MgCl2, 1 mM DTT, 0.2 mM EDTA, and 10% glycerol, in a molar ratio of 1:1:1:1:1.05. The mixture was incubated at 65°C for 3 minutes, followed by a cooling step to 4°C.

  5. User

    The RNA substrates were purchased from Takara, and they were site-specifically 32P-labeled as previously described. Briefly, the 3'-half of a substrate was 5' 32P -labeled by T4 PNK in the presence of γ-32P ATP. After that, the 5'-half and 3'-half RNAs were annealed to a splint DNA and ligated with T4 RNA ligase 2 (NEB; M0239S). The full-length substrates were purified by 20% polyacrylamide urea gel. The reaction mixture comprised 10 pmol of H/ACA RNP and ~1 pmol of 32P-labeled substrate in 10 µL of reaction buffer (20 mM HEPES (pH 8.2), 150 mM NaCl, 10 mM MgCl2, 1 mM DTT, 0.2 mM EDTA and 10% glycerol) and was performed at 65°C for 30 minutes. The RNA was extracted with an equal volume of phenol/chloroform/isoamyl alcohol and precipitated with ethanol. The RNA was dissolved in 5 µL of RNase A and S7 nuclease solution. The resulting digested 3'-P nucleotides were then resolved using thin layer chromatography and visualized through phosphorimaging (Typhoon, GE Healthcare).

  6. Assistant

    The RNA substrates, purchased from Takara, were site-specifically labeled with 32P as described previously. In brief, T4 PNK was used to 5'-label the 3'-half of the substrate with γ-32P ATP in the presence of a splint DNA. The 5'-half and 3'-half RNAs were then annealed and ligated using T4 RNA ligase 2 (NEB; M0239S), and full-length substrates were purified using a 20% polyacrylamide urea gel. The reaction mixture consisted of ~1 pmol of 32P-labeled substrate and 10 pmol of H/ACA RNP in 10 µL of reaction buffer (20 mM HEPES (pH 8.2), 150 mM NaCl, 10 mM MgCl2, 1 mM DTT, 0.2 mM EDTA, and 10% glycerol) and was incubated at 65°C for 30 minutes. The RNA was then extracted with an equal volume of phenol/chloroform/isoamyl alcohol and precipitated with ethanol. The RNA sample was treated with RNase A and S7 nuclease, and the resulting digested 3'-P nucleotides were then separated using thin layer chromatography and visualized through phosphorimaging (Typhoon, GE Healthcare).

  7. User

    The RNA substrates, purchased from Takara, were site-specifically 32P-labeled as previously described (Li et al., 2011). In brief, the 3'-half RNA was 5'-32P -labeled by T4 PNK in the presence of γ-32P ATP. After that, the 5'-half RNA, 5'-32P -labeled 3'-half RNA, and splint DNA were annealed and ligated with T4 RNA ligase 2 (NEB; M0239S). The full-length substrates were purified by 20% polyacrylamide urea gel.

  8. Assistant

    The RNA substrates, which were purchased from Takara, were specifically labeled with 32P as reported in previous studies (Li et al., 2011). Initially, the 3'-half RNA was labeled with γ-32P ATP using T4 PNK. Subsequently, the 5'-half RNA, the 5'-32P labeled 3'-half RNA, and splint DNA were annealed and ligated with T4 RNA ligase 2 (NEB; M0239S). Finally, the full-length substrates were purified using a 20% polyacrylamide urea gel.

  9. User

    The reaction mixture comprised 10 pmol of H/ACA RNP and ~1 pmol of 32P-labeled substrate in 10 µL of reaction buffer (20 mM HEPES (pH 8.2), 150 mM NaCl, 10 mM MgCl2, 1 mM DTT, 0.2 mM EDTA and 10% glycerol) and was performed at 65°C for 30 minutes. The RNA was extracted with an equal volume of phenol/chloroform/isoamyl alcohol and precipitated with ethanol. The RNA was dissolved in 5 µL of RNase A and S7 nuclease solution. The resulting digested 3'-P nucleotides were then resolved using thin layer chromatography and visualized through phosphorimaging (Typhoon, GE Healthcare).

  10. Assistant

    The reaction mixture contained approximately 1 pmol of 32P-labeled substrate and 10 pmol of H/ACA RNP in 10 µL of reaction buffer (20 mM HEPES (pH 8.2), 150 mM NaCl, 10 mM MgCl2, 1 mM DTT, 0.2 mM EDTA, and 10% glycerol) and was carried out at 65°C for 30 minutes. The RNA was extracted with an equal volume of phenol/chloroform/isoamyl alcohol and precipitated with ethanol. The RNA sample was then dissolved in 5 µL of RNase A and S7 nuclease solution to digest the resulting 3'-P nucleotides. Thin layer chromatography was used to separate the digested nucleotides which were visualized via phosphorimaging (Typhoon, GE Healthcare).

  11. User

    A reaction mixture consisting of 300 pmol of H/ACA RNP and 300 pmol of the substrate was subjected to in vitro assembly in the reaction buffer at 65°C. The modified RNA was extracted by phenol/chloroform/isoamyl alcohol and precipitated with ethanol following the completion of the reaction. The RNA was then treated with CMC and reverse transcribed using specific primers, following the Ψ-seq library construction protocol. Subsequently, RNA templates were digested with RNase H (M0297S, NEB), and the obtained cDNA products were separated on polyacrylamide urea gel to select the desired size range of the cDNA fragments.

  12. Assistant

    For in vitro assembly, a reaction mixture containing 300 pmol of H/ACA RNP and 300 pmol of the substrate was prepared in the reaction buffer and incubated at 65°C. Following the completion of the reaction, the modified RNA was extracted using phenol/chloroform/isoamyl alcohol and then precipitated with ethanol. The RNA was then treated with CMC, followed by reverse transcription using specific primers, in accordance with the Ψ-seq library construction protocol. Next, the RNA templates were digested with RNase H (M0297S, NEB), and the resulting cDNA products were separated in a polyacrylamide urea gel to select the desired size range of the cDNA fragments.

  13. User

    Similar to the process of Ψ-seq, the RNA is divided into two parts, one part is treated with CMC and sodium carbonate in turn, and the other part is not treated with CMC

  14. Assistant

    Similar to the Ψ-seq process, the RNA is divided into two parts. One part is treated with CMC and then sodium carbonate, while the other part is not treated with CMC.

  15. User

    revise the sentence. Similar to the process of Ψ-seq, the RNA is divided into two parts, one part is treated with CMC and sodium carbonate in turn, and the other part is not treated with CMC

  16. Assistant

    Similar to the Ψ-seq approach, the RNA is divided into two parts; one is subjected to treatment with CMC, followed by sodium carbonate treatment, while the other part is left untreated with CMC.

  17. User

    Similar to the Ψ-seq method, the RNA is divided into two fractions; one is added with CMC and then treated with sodium carbonate, while the other is without CMC.

  18. Assistant

    The RNA is divided into two portions using a methodology similar to Ψ-seq. One of the fractions is treated with CMC followed by sodium carbonate, while the other fraction remains untreated with CMC.

  19. User

    The RNA is divided into two portions using a methodology similar to Ψ-seq. One of the fractions is treated with CMC followed by sodium carbonate, while the other fraction remains untreated with CMC. Then reverse-transcribed using specific primers.

  20. Assistant

    After being separated into two portions, similar to the Ψ-seq protocol, one fraction of the RNA is treated with CMC followed by sodium carbonate, while the other fraction is left untreated with CMC. The RNA is then reverse-transcribed using specific primers.

  21. User

    As a control, we also performed the same operation on unmodified RNA at the same time

  22. Assistant

    As a control, we carried out the same procedure on the unmodified RNA simultaneously.

  23. User

    Subsequently, RNA templates were digested with RNase H (M0297S, NEB), and the obtained cDNA products were separated on polyacrylamide urea gel to select the desired size range of the cDNA fragments. As a control, we carried out the same procedure on the unmodified RNA simultaneously.

  24. Assistant

    After reverse transcription, the RNA templates were subjected to RNase H digestion (M0297S, NEB), and the resulting cDNA products were separated on a polyacrylamide urea gel to select cDNA fragments within a particular size range. As a control, we also performed the same procedure on the unmodified RNA simultaneously.

  25. User

    Subsequently, the RNA templates were digested with RNase H (M0297S, NEB), and the obtained cDNA products were separated on polyacrylamide urea gel to observe the desired size range of the cDNA fragments.

  26. Assistant

    Next, the RNA templates were digested with RNase H (M0297S, NEB), and the resulting cDNA products were separated on a polyacrylamide urea gel to confirm the presence and observe the size distribution of the desired cDNA fragments.

  27. User

    Subsequently, the RNA templates were digested with RNase H (M0297S, NEB), and the obtained cDNA products were separated on polyacrylamide urea gel to confirm the presence of the expected cDNA fragment.

  28. Assistant

    After RNase H digestion and reverse transcription, the RNA templates were subjected to electrophoresis on a polyacrylamide urea gel to confirm the presence of the expected cDNA fragment.

  29. User

    To prepare competent cells, cells with OD600=0.3 were harvested by centrifugation at 20°C, washed three times with 20 mM sucrose, resuspended in 20 mM sucrose and stored at temperature of -80 °C.

  30. Assistant

    To produce competent cells, cells with an OD600 of 0.3 were harvested by centrifugation at 20°C, washed three times with 20 mM sucrose, and then resuspended in 20 mM sucrose. The cells were subsequently stored at a temperature of -80 °C.

  31. User

    A spacer sequence designed to target the original insertion site was chemically synthesized and inserted into the BspMI sites of pSe-Rp through restriction cleavage and ligation using T4 DNA ligase. The donor DNA comprises the inserted or mutated sequence flanked by two arm sequences derived from the chromosomal target site. Two arm sequences were PCR amplified from S. islandicus genomic DNA. After cleavage at the SalI and NotI sites, the vector was linearized and then ligated with the donor DNA using the In-fusion method. The resulting plasmid was transformed into S. islandicus competent cells by electroporation. Subsequently, the transformed cells were plated on uracil-deficient medium, and clones were selected by a PCR-based assay and sequencing.

  32. Assistant

    To target the original insertion site, a spacer sequence was synthesized chemically and inserted into the BspMI sites of pSe-Rp through restriction cleavage and ligation, utilizing T4 DNA ligase. The donor DNA consisted of the inserted or mutated sequence, flanked by two arm sequences derived from the chromosomal target site. These arm sequences were amplified from the S. islandicus genomic DNA via PCR. Following cleavage at the SalI and NotI sites, the vector was linearized and then ligated with the donor DNA utilizing the In-fusion method. The resulting plasmid was introduced into S. islandicus competent cells via electroporation. Following this, the transformed cells were plated on uracil-deficient medium, and clones were selected via PCR-based assay and sequencing.

  33. User

    In this way, 3×Flag and 6×His epitope tags were inserted into the C-terminus of the chromosome Cbf5 gene, and part of the genes of aPus7, sR109, sR148 and sR563 were removed.

  34. Assistant

    By utilizing this process, the C-terminus of the chromosome Cbf5 gene was modified, with the inclusion of 3×Flag and 6×His epitope tags. Additionally, a portion of the genes of aPus7, sR109, sR148, and sR563 were removed.

  35. User

    By this way, a 3×Flag and 6×His epitope tag was inserted into the C-terminus of chromosomal Cbf5 gene. Additionally, the individual genes of aPus7, sR109, sR148 and sR563 were removed.

  36. Assistant

    This procedure resulted in the insertion of a 3×Flag and 6×His epitope tag into the C-terminus of the chromosomal Cbf5 gene, along with the removal of the individual genes of aPus7, sR109, sR148, and sR563.

  37. User

    Cells expressing Cbf5-FH were harvested and resuspended in buffer S (100mM MOPS pH 7.4, 300mM NaCl and 10% glycerol), supplemented with protease inhibitor tablets (Roche).

  38. Assistant

    Cells that were expressing Cbf5-FH were collected by centrifugation and suspended in buffer S, which contained 100 mM MOPS pH 7.4, 300 mM NaCl, and 10% glycerol. Additionally, the buffer was supplemented with protease inhibitor tablets from Roche to ensure proper stabilization of the proteins.

  39. User

    Cells expressing Cbf5-FH were harvested by centrifugation and resuspended in buffer S (100mM MOPS pH 7.4, 300mM NaCl and 10% glycerol), supplemented with protease inhibitor tablets (Roche).

  40. Assistant

    Cells expressing Cbf5-FH were harvested via centrifugation and subsequently suspended in buffer S, which comprised 100 mM MOPS pH 7.4, 300 mM NaCl, and 10% glycerol. Moreover, protease inhibitor tablets from Roche were added to the buffer to ensure proper stabilization of the proteins